CRIS Current Research Information System

MONTI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.803
NA - Nord America 6.399
EU - Europa 5.109
AF - Africa 472
SA - Sud America 364
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 2
Totale 19.177
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.253
IT - Italia 1.943
SG - Singapore 1.740
CN - Cina 1.586
VN - Vietnam 1.544
HK - Hong Kong 757
GB - Regno Unito 720
DE - Germania 479
SE - Svezia 385
IN - India 300
FR - Francia 271
BR - Brasile 256
KR - Corea 207
JP - Giappone 198
NL - Olanda 197
RU - Federazione Russa 194
CI - Costa d'Avorio 160
IE - Irlanda 131
FI - Finlandia 125
UA - Ucraina 111
TG - Togo 110
ZA - Sudafrica 109
TW - Taiwan 98
CA - Canada 89
ES - Italia 83
AT - Austria 69
PH - Filippine 58
BG - Bulgaria 56
CH - Svizzera 51
AR - Argentina 44
MX - Messico 42
PT - Portogallo 42
BD - Bangladesh 41
EE - Estonia 40
BE - Belgio 39
PL - Polonia 37
ID - Indonesia 36
JO - Giordania 33
NG - Nigeria 32
IR - Iran 31
TR - Turchia 30
HR - Croazia 29
SC - Seychelles 29
TH - Thailandia 28
GR - Grecia 23
EC - Ecuador 22
AU - Australia 21
PK - Pakistan 21
IQ - Iraq 18
RO - Romania 18
CZ - Repubblica Ceca 15
SA - Arabia Saudita 13
CL - Cile 12
MY - Malesia 10
UZ - Uzbekistan 10
NO - Norvegia 9
PY - Paraguay 9
LT - Lituania 7
NP - Nepal 7
NZ - Nuova Zelanda 7
CO - Colombia 6
HU - Ungheria 6
LB - Libano 6
LI - Liechtenstein 6
VE - Venezuela 6
AZ - Azerbaigian 5
IL - Israele 5
KE - Kenya 5
SN - Senegal 5
AE - Emirati Arabi Uniti 4
CU - Cuba 4
DO - Repubblica Dominicana 4
LV - Lettonia 4
SI - Slovenia 4
UY - Uruguay 4
DK - Danimarca 3
DZ - Algeria 3
JM - Giamaica 3
MU - Mauritius 3
PE - Perù 3
PS - Palestinian Territory 3
TN - Tunisia 3
TZ - Tanzania 3
AL - Albania 2
ET - Etiopia 2
KG - Kirghizistan 2
KH - Cambogia 2
MA - Marocco 2
MK - Macedonia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
EG - Egitto 1
Totale 19.159
Salva come PNG Salva come JPEG
Città #
Singapore 1.237
Ashburn 724
Bologna 709
Hong Kong 635
Southend 550
Chandler 490
Fairfield 465
Hefei 371
Ho Chi Minh City 367
San Jose 364
Hanoi 337
Dallas 299
Ann Arbor 253
Woodbridge 240
Santa Clara 227
Houston 197
Cambridge 194
Wilmington 192
Seattle 182
Los Angeles 181
Beijing 180
Seoul 166
Abidjan 160
Tokyo 149
Princeton 147
Dublin 130
Boardman 118
Council Bluffs 111
Lomé 110
Helsinki 104
Lauterbourg 98
Turin 95
Milan 94
New York 93
Redmond 70
Da Nang 68
Berlin 65
Dong Ket 63
Nanjing 63
Vienna 55
Westminster 53
Johannesburg 51
Frankfurt am Main 48
Sofia 48
Jacksonville 45
Padova 45
Bengaluru 43
Buffalo 42
Haiphong 41
Chicago 40
Redondo Beach 39
Forlì 37
London 37
Rome 37
São Paulo 36
Brussels 35
Guangzhou 35
Saint Petersburg 35
Munich 34
Amman 33
Taipei 32
Bern 31
Changsha 31
San Diego 30
Abeokuta 28
Jinan 27
Medford 27
Shanghai 27
Brooklyn 26
Falls Church 26
Bari 25
Hyderabad 25
Hải Dương 25
Biên Hòa 24
Reggio Emilia 24
Tianjin 24
Warsaw 24
Montreal 23
Amsterdam 22
Des Moines 22
Falkenstein 22
Phoenix 22
Toronto 21
Jakarta 20
Rimini 20
Boston 19
Can Tho 19
Washington 19
Dearborn 18
Nuremberg 18
Kaohsiung 17
Modena 17
Paris 17
Redwood City 17
Shenyang 17
Yubileyny 17
Barcelona 16
Mexico City 16
Nanchang 15
New Delhi 15
Totale 12.052
Salva come PNG Salva come JPEG
Nome #
Cell-Based Assays to Assess Neuroprotective Activity 567
A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential 438
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease 423
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. 394
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 325
Characterization of DNA methylation as a function of biological complexity via dinucleotide inter-distances 304
Melatonin- And Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects in Vitro and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model 293
Histone Acetylation Defects in Brain Precursor Cells: A Potential Pathogenic Mechanism Causing Proliferation and Differentiation Dysfunctions in Mitochondrial Aspartate-Glutamate Carrier Isoform 1 Deficiency 288
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) 284
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation. 279
Dysregulation of long non-coding RNAs in neuroinflammation: characterization of LINC00520 and its possible role in Parkinson's disease 276
Deficiency of Mitochondrial Aspartate-Glutamate Carrier 1 Leads to Oligodendrocyte Precursor Cell Proliferation Defects Both In Vitro and In Vivo 273
Metabolic supplementations and epigenetic alterations in in vitro AGC1 deficiency models 271
Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer's Disease 271
Characterization of the lncRNA LINC00520 in the developing and adult central nervous system and its correlation to neurodegenerative processes 259
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors 257
Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches 255
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo 247
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease 243
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer 233
Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease 227
N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study 227
Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose 225
Up-regulation of LINC00520 in in vitro models of Parkinson's disease: searching for a physiological role and dysregulation in neurodegeneration 224
Chronic treatment with hormonal contraceptives alters hippocampal BDNF and histone H3 post-translational modifications but not learning and memory in female rats 223
Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer's Disease. 222
Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection 222
α-linolenic acid-valproic acid conjugates: Toward single-molecule polypharmacology for multiple sclerosis 221
Targeted quantitative metabolic profiling of brain-derived cell cultures by semi-automated MEPS and LC-MS/MS 217
In vitro and in vivo toxicity of type 2 ribosome-inactivating proteins lanceolin and stenodactylin on glial and neuronal cells. 214
Correction to: Selection of suitable reference genes for gene expression studies in HMC3 cell line by quantitative real-time RT-PCR (Scientific Reports, (2024), 14, 1, (2431), 10.1038/s41598-024-52415-7) 213
Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity 213
Neuronal Regulation of Neuroprotective Microglial Apolipoprotein E Secretion in Rat In Vitro Models of Brain Pathophysiology. 211
Tampering with microglia-mediated neuroinflammation by means of DNA nanostructures 211
Long INterspersed nuclear Elements (LINEs) in brain and non-brain tissues of the rat 208
Transcriptional and metabolic effects of aspartate-glutamate carrier isoform 1 (AGC1) downregulation in mouse oligodendrocyte precursor cells (OPCs) 207
Dietary Protein Source Influences Brain Inflammation and Memory in a Male Senescence-Accelerated Mouse Model of Dementia 206
Unveiling the role of exosomal miRNAs in the spreading of neuroinflammation 205
Targeting Lewy body dementia with neflamapimod-rasagiline hybrids 203
Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death. 201
Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects 198
Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta2 198
Valproic acid neuroprotection in 6-OHDAlesioned rat, a model for parkinson's disease 196
Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease 192
Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis 191
Progetto Telethon GGP11139 “Mitochondrial Aspartate/Glutamate Carrier 1 Deficiency: Pathogenetic Mechanisms and Mutational Analysis” (2011-2014) 191
Evidence for purine nucleoside phosphorylase (PNP) release from RAT C6 glioma cells. 191
Selection of suitable reference genes for gene expression studies in HMC3 cell line by quantitative real-time RT-PCR 187
The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms. 183
CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients 183
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy 182
Histone post-translational modifications in Huntington's and Parkinson's diseases. 179
Investigating the role of lncRNAs in CNS pathophysiology: LINC00520 as a potential biomarker for Parkinson’s disease in human in vitro models 177
Chronic valproic acid administration impairs contextual memory and dysregulates hippocampal GSK-3β in rats. 177
New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents 177
Dysregulation of memory-related proteins in the hippocampus of aged rats and their relation with cognitive impairment. 176
Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha synuclein 176
From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease 171
Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients. 169
Alterations of markers related to synaptic function in aging rat brain, in normal conditions or under conditions of long-term dietary manipulation 161
Neuronal-glial Interactions Define the Role of Nitric Oxide in Neural Functional Processes 161
Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice 160
Unveiling the antitumor mechanism of 7α-acetoxy-6β-hydroxyroyleanone from Plectranthus hadiensis in glioblastoma 159
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity. 157
Memory-enhancing drugs: a molecular perspective 156
Subchronic rolipram delivery activates hippocampal CREB and Arc. enhances retention and slows down extinction of conditioned fear. 155
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy in Vitro and in Vivo in an Alzheimer's Disease Mouse Model 154
Ketone bodies resume mitochondrial respiration in neuronal progenitors from iPSCs of patients with AGC1 deficiency 152
Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis 151
Microglia and neuroprotection: from in vitro studies to therapeutic applications. 151
Microstructured soft devices for the growth and analysis of populations of homogenous multicellular tumor spheroids 151
New models of Parkinson’s like neuroinflammation in human microglia clone 3: Activation profiles induced by INF-γ plus high glucose and mitochondrial inhibitors 148
Activation of human microglia clone 3 (HMC3) in response to stress conditions: are long non-coding RNAs involved? 146
The bivalent ligand approach as a tool for improving the in vitro anti-Alzheimer multitarget profile of dimebon 146
Interplay between circadian rhythms and epigenetics in neural stem cells and Alzheimer's disease 140
Release of soluble and vesicular purine nucleoside phosphorylase from rat astrocytes and microglia induced by pro-inflammatory stimulation with extracellular ATP via P2X7 receptors. 140
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors 140
Down-regulation of the mitochondrial aspartate-glutamate carrier isoform 1 AGC1 inhibits proliferation and N-acetylaspartate synthesis in Neuro2A cells. 138
Updating the dual role of brain nitric oxide in neurodegeneration/neuroprotection: understanding molecular mechanisms to devise drug approaches. 137
Telethon GGP19067-2019 - "Alla ricerca di nuovi bersagli terapeutici per contrastare l’ipomielinizzazione nell’AGC1 deficiency: uno studio multidisciplinare sui precursori delle cellule cerebrali". 131
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer's Disease Mouse Model. 129
Design, synthesis and pharmacological evaluation of multitarget GPR40 agonists/HDAC6 inhibitors for Alzheimer's disease 118
Histone post-translational modifications to target memory-related diseases. 118
Epigenetic mechanisms underlying opiate dependence. 114
Bio-organic self-assembled DNA nanostructures and their use in the mitigation of the activation of microglia in neuroinflammation 111
Neuroprotezione e meccanismi molecolari delle interazioni tra microglia e neuroni: studio cellulare, funzionale e comportamentale. 104
Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease 104
Coumarin-azasugar-benzyl conjugates as non-neurotoxic dual inhibitors of butyrylcholinesterase and cancer cell growth 100
null 98
Science on both sides of Atlantic (I,II and III) 96
null 91
Zinc supplementation in rats impairs hippocampal-dependent memory consolidation and dampens post-traumatic recollection of stressful event. 90
A nutritional approach to tackle Alzheimer's disease: a key role for immunomodulation 88
Guest editor della special Issue "Microglia in neurodegeneration" nella sezione "Molecular Biology" della rivista Biomolecules 88
Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based Inhibitors 87
null 85
null 85
null 85
Exploiting acylaminopyrazole scaffold for polypharmacology approach in Alzheimer's disease 81
null 79
Totale 19.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.934
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021410 0 0 0 0 0 0 0 0 0 84 101 225
2021/20221.714 131 45 89 74 152 103 87 183 131 159 278 282
2022/20232.238 204 348 133 227 151 180 79 145 351 93 188 139
2023/2024999 94 102 71 77 69 182 56 116 38 69 88 37
2024/20253.054 174 328 263 221 368 173 239 184 101 250 203 550
2025/20267.973 613 766 805 681 820 451 1.634 355 1.408 440 0 0
Totale 19.587